What Is a Heart Screening? Tests, Results & Coverage

A heart screening is any test or combination of tests used to check for cardiovascular disease in someone who does not yet have symptoms. The specifics vary widely depending on your age, risk factors, and what your doctor is looking for: options range from a simple blood draw for cholesterol to advanced imaging that maps calcium deposits inside your coronary arteries. No single test qualifies as “the” heart screening. Instead, screening typically begins with a risk assessment based on your age, blood pressure, cholesterol, smoking status, and family history, and additional tests are layered on when that initial picture suggests you need a closer look.

The Electrocardiogram

The electrocardiogram, usually called an ECG or EKG, is one of the most familiar heart tests. Electrodes stuck to your chest record the electrical activity of your heart over a few seconds (a resting ECG) or while you walk on a treadmill (an exercise ECG). Doctors have used it for over a century, and it remains a quick, cheap, widely available test. But as a general screening tool for people who feel fine, the evidence is surprisingly weak. A systematic review found that no study had directly compared clinical outcomes in people who were screened with an ECG versus those who were not, and that abnormalities on a resting or exercise ECG were linked to higher cardiovascular risk but without clear clinical implications for what to do about it.

The U.S. Preventive Services Task Force has taken a firm stance: it recommends against ECG screening in asymptomatic adults at low cardiovascular risk and says there is not enough evidence to judge the balance of benefits and harms for people at intermediate or high risk.¹ That does not mean the ECG is useless. It is excellent when you have symptoms like chest pain, palpitations, or shortness of breath. It just has not been shown to improve outcomes when used to screen healthy people at routine checkups.²

Blood Tests That Flag Heart Risk

Most people’s first encounter with heart screening is a blood draw. A standard lipid panel measures total cholesterol, LDL (“bad”) cholesterol, HDL (“good”) cholesterol, and triglycerides. These numbers feed directly into risk calculators that estimate your chance of a heart attack or stroke over the next ten years. For many adults, this is the only screening they need.

Beyond the basic lipid panel, two blood markers have gained attention. High-sensitivity C-reactive protein (hsCRP) measures inflammation in the body, and lipoprotein(a), or Lp(a), is a genetically determined cholesterol particle that raises cardiovascular risk. What makes these interesting is how they interact. In a large study following participants for an average of about 14 years, elevated Lp(a) alone or elevated hsCRP alone did not raise cardiovascular risk much. But when both were high, the combination was independently linked to a roughly 60% increase in cardiovascular events and about a 40% increase in death from any cause.³ This suggests that checking both markers together gives a more meaningful picture than either one alone, particularly for people whose standard risk scores put them in an uncertain middle zone.

Coronary Artery Calcium Scoring

A coronary artery calcium (CAC) score comes from a quick, low-dose CT scan of your heart. It detects calcified plaque inside your coronary arteries, which is a direct sign of atherosclerosis. The result is a number: zero means no detectable calcium, and scores climb into the hundreds or thousands as plaque accumulates. Traditional risk calculators rely on indirect markers like cholesterol levels and blood pressure. CAC scoring lets doctors see actual disease in the arteries, which is why it has been shown to significantly improve how accurately people are placed into risk categories.⁴

That reclassification matters in practice. Relying only on traditional risk factors can lead to both undertreatment, where someone with hidden plaque gets no medication, and overtreatment, where someone without plaque takes a statin they do not need.⁵ A score of zero is particularly reassuring and often allows doctors to defer statin therapy even if your calculated risk is borderline. A high score can push the conversation toward more aggressive prevention. The test takes about ten minutes and does not require contrast dye, though it does involve a small dose of radiation.⁶

Stress Tests and Echocardiography

Stress testing pushes your heart to work harder, either through exercise on a treadmill or with a drug that mimics exercise, while doctors monitor your ECG, blood pressure, and sometimes ultrasound images of your heart. The idea is that problems hidden at rest, like a narrowed artery that limits blood flow only during exertion, will reveal themselves. Stress echocardiography combines this with real-time ultrasound imaging to watch how your heart muscle contracts under load.

Stress tests are most useful when there is already a reason to suspect coronary artery disease. In certain high-risk groups, they can find hidden trouble: a study of people with type 2 diabetes and additional risk factors found that exercise ECG stress testing had about 79% accuracy for detecting coronary artery disease, though it missed about 18% of cases, particularly in those who had lived with diabetes longer.⁷ No test is perfect, and false positives on stress echocardiography do occur, sometimes leading to invasive procedures that turn out to be unnecessary. This is one reason stress tests are generally reserved for people with moderate-to-high suspicion rather than used as blanket screening.

CT Coronary Angiography

CT coronary angiography (CTCA) goes a step beyond calcium scoring. It uses contrast dye injected into a vein to produce detailed images of the coronary arteries, showing not just calcified plaque but also soft plaque and the degree of narrowing. It has high sensitivity and a very high negative predictive value, meaning that if the scan looks clear, you almost certainly do not have significant blockages.⁸

The trade-off is radiation exposure and what happens downstream. In the PROMISE trial, patients who started with CTCA were more likely to be referred for invasive catheterization and revascularization procedures compared with those who began with functional testing like stress tests.⁸ Some of those additional procedures may catch real disease earlier, but some may be driven by the test finding borderline abnormalities that would never have caused problems. For younger patients and women, the cumulative radiation from CT imaging is also a relevant consideration. CTCA is usually not a first-line screening test for people without symptoms; it is most valuable when someone has chest pain or other signs of possible angina and the doctor needs to see the arteries directly.

What Your Results Mean and What Comes Next

A screening result does not end the conversation; it reshapes it. A normal ECG, a calcium score of zero, or a clean lipid panel generally means continuing whatever you are already doing, often with a plan to recheck in a few years. An abnormal result, on the other hand, can set off a cascade of follow-up tests, medication discussions, and lifestyle changes.

If your calcium score is elevated, your doctor will likely talk about starting or intensifying statin therapy. If a stress test shows possible blockages, the next step is often catheterization to look at the arteries directly. Comparative modeling has found that newer risk-stratification guidelines that identify more people for statin treatment can be more cost-effective than older, more conservative guidelines, even though they put millions more people on medication.⁹ The practical takeaway for you: an abnormal screening test does not necessarily mean you are about to have a heart attack. It means your risk profile has changed, and the decisions about prevention, whether that is diet, exercise, medication, or more testing, need to reflect that change.

Screening Young Athletes

Heart screening takes on a different urgency for young competitive athletes, where the primary concern is not gradual coronary artery disease but rather structural or electrical abnormalities that can cause sudden cardiac death during intense exertion. The standard screening for student athletes in the United States relies on a health history and physical exam, which is inexpensive and easy to administer but not especially good at catching the conditions that kill young athletes.

Adding an ECG to that screening dramatically improves detection. A meta-analysis of studies covering about 28,000 athletes aged 10 to 35 found that the history and physical exam alone did not have a statistically significant association with detecting conditions related to sudden cardiac death, while ECG screening had a far stronger association with detection.¹⁰ Despite this, whether to include ECG or cardiac imaging in routine pre-participation screening remains contested, partly because sudden cardiac death in athletes is rare in absolute terms and false positives can sideline healthy athletes unnecessarily.¹¹ Italy has mandated ECG screening for competitive athletes for decades; the United States has not. The debate comes down to cost, scale, and how many false alarms a system is willing to tolerate for each real catch.

Genetic Testing for Inherited Heart Conditions

Some cardiovascular risks are written into your DNA. Familial hypercholesterolemia (FH) is a genetic condition that causes dangerously high LDL cholesterol from birth, leading to early heart disease if untreated. It affects roughly one in 250 people, but most cases go undiagnosed because cholesterol screening alone does not always flag it.

Genetic testing can identify FH cases that clinical criteria miss, improve how accurately risk is estimated beyond just looking at cholesterol numbers and family history, and help guide treatment decisions.¹² But the relationship between genetics and cholesterol levels is not straightforward. In large population studies, only about 2% of people with very high LDL cholesterol actually carried a genetic variant known to cause FH.¹³ That means most people with high cholesterol do not have the genetic form of the disease. Genetic testing is most valuable when someone has very high LDL, a strong family history of early heart disease, or cholesterol that does not respond well to standard treatment. It is not yet used as a mass-screening tool for the general population.

Wearable Monitors and AI-Powered Screening

Smartwatches and wearable devices have introduced a form of heart screening that runs continuously on your wrist. The most studied application is detecting atrial fibrillation, an irregular heart rhythm that raises the risk of stroke. In a landmark study involving hundreds of thousands of participants, the positive predictive value of a smartwatch notification for atrial fibrillation was about 84% when checked against a simultaneous ECG recording.¹⁴ A more recent randomized trial found that people using a smartwatch with atrial fibrillation detection were about four times more likely to have new-onset atrial fibrillation diagnosed compared with a control group, including several cases that were completely asymptomatic and would have gone undetected otherwise.¹⁵

Artificial intelligence is expanding what an ordinary ECG can reveal. AI algorithms trained on massive datasets can now extract information from ECG tracings that a human eye cannot see, including early signs of weakened heart pumping that have not yet caused symptoms. One AI model applied to a standard 12-lead ECG detected asymptomatic left ventricular dysfunction with about 86% sensitivity and 86% specificity. Even more striking, people whose AI screen was positive but who did not yet have heart dysfunction were about four times more likely to develop it in the future than those who screened negative.¹⁶ AI is also being applied to detect arrhythmias, subtle ST-segment changes, and other abnormalities, and to clean up noisy ECG signals to improve accuracy.¹⁷ These tools are still maturing, but they point toward a future where a cheap, routine ECG becomes a much more powerful screening instrument than it is today.

Occupational Heart Screening

Certain jobs require more rigorous heart screening than the general population gets. Airline pilots, firefighters, military personnel, and others in high-hazard occupations face regular cardiovascular evaluations because their incapacitation on the job could endanger others. For commercial airline pilots, for example, the widely used benchmark is the “1% rule,” which caps the acceptable risk of pilot incapacitation at less than 1% per year. Screening in these settings typically includes a history and physical exam, validated cardiovascular risk factor measurement, a resting ECG, and an objective test of cardiorespiratory fitness.¹⁸

These programs are one of the few settings where ECG screening of asymptomatic individuals is considered clearly worthwhile, because the consequences of a missed diagnosis are catastrophic and the population being screened is defined and manageable. Firefighters, for instance, face aerobic fitness thresholds tied directly to their ability to perform operational duties safely. Occupational heart screening is one of the clearest examples of how context changes the risk-benefit math: the same ECG that the USPSTF says has unclear value for a random healthy adult becomes indispensable when that adult flies a commercial aircraft.

Who Pays for Heart Screening

Coverage for heart screening in the United States depends heavily on what test you are talking about and why it is being ordered. Under the Affordable Care Act, preventive services rated “A” or “B” by the USPSTF must be covered without cost-sharing by most insurance plans. Cholesterol screening for adults meets that bar and is covered. Standard blood pressure checks at a wellness visit are covered. But the ECG for asymptomatic screening received a “D” rating for low-risk adults and an “I” (insufficient evidence) rating for higher-risk adults, which means insurers are not required to cover it as a preventive test.

Coronary artery calcium scoring occupies an awkward spot. Many cardiologists consider it valuable for people at intermediate risk, but Medicare and most private insurers do not routinely cover it. Out-of-pocket costs for a CAC scan typically run between $75 and $400, depending on your location. Genetic testing for conditions like familial hypercholesterolemia is covered by some plans when clinical criteria are met, but coverage varies widely. Advanced imaging like CT angiography and stress echocardiography are generally covered when ordered to evaluate symptoms or follow up on abnormal findings, but not as first-line screening in people who feel fine.

Who Actually Gets Screened and Who Gets Missed

Even when screening tests are available and covered, not everyone receives them equally. A study examining cholesterol screening disparities found that differences in screening rates between white, Black, and Hispanic adults were largely explained by lower socioeconomic status, lack of healthcare access, and language barriers rather than by race itself. Expanding insurance coverage and improving access to culturally appropriate care were identified as the most promising strategies for closing those gaps.¹⁹

Sex-based differences in screening also deserve attention. A Dutch study of primary care patients found that women were actually more likely than men to have most individual cardiovascular risk factors measured, including blood pressure, cholesterol fractions, and kidney function. But when women had high LDL cholesterol, they were less likely to be prescribed lipid-lowering medication compared with men, and among those on lipid-lowering treatment, women were less likely to reach target LDL levels.²⁰ The screening itself happened, in other words, but the follow-through was unequal. Getting a test is only half the equation; what happens afterward determines whether screening actually prevents disease.